Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Breast Cancer

  Free Subscription


Articles published in JAMA

Retrieve available abstracts of 39 articles:
HTML format
Text format



Single Articles


    February 2017
  1. SACKEIM MG
    Eradicating a Genetic Mutation.
    JAMA. 2017;317:809.
    PubMed     Text format    


  2. ALLEN D
    Moving the Needle on Recovery From Breast Cancer: The Healing Role of Postmastectomy Tattoos.
    JAMA. 2017;317:672-674.
    PubMed     Text format    


  3. RUGO HS, Klein P, Melin SA, Hurvitz SA, et al
    Association Between Use of a Scalp Cooling Device and Alopecia After Chemotherapy for Breast Cancer.
    JAMA. 2017;317:606-614.
    PubMed     Text format     Abstract available


  4. NANGIA J, Wang T, Osborne C, Niravath P, et al
    Effect of a Scalp Cooling Device on Alopecia in Women Undergoing Chemotherapy for Breast Cancer: The SCALP Randomized Clinical Trial.
    JAMA. 2017;317:596-605.
    PubMed     Text format     Abstract available


  5. HERSHMAN DL
    Scalp Cooling to Prevent Chemotherapy-Induced Alopecia: The Time Has Come.
    JAMA. 2017;317:587-588.
    PubMed     Text format    


  6. MUTH CC
    Chemotherapy and Hair Loss.
    JAMA. 2017;317:656.
    PubMed     Text format    


  7. KURIAN AW, Griffith KA, Hamilton AS, Ward KC, et al
    Genetic Testing and Counseling Among Patients With Newly Diagnosed Breast Cancer .
    JAMA. 2017;317:531-534.
    PubMed     Text format    


    January 2017
  8. BRAGG F, Holmes MV, Iona A, Guo Y, et al
    Association Between Diabetes and Cause-Specific Mortality in Rural and Urban Areas of China.
    JAMA. 2017;317:280-289.
    PubMed     Text format     Abstract available


  9. HIMELSTEIN AL, Foster JC, Khatcheressian JL, Roberts JD, et al
    Effect of Longer-Interval vs Standard Dosing of Zoledronic Acid on Skeletal Events in Patients With Bone Metastases: A Randomized Clinical Trial.
    JAMA. 2017;317:48-58.
    PubMed     Text format     Abstract available


    December 2016
  10. BURSTEIN HJ, Schrag D
    Biosimilar Therapy for ERBB2 (HER2)-Positive Breast Cancer: Close Enough?
    JAMA. 2016 Dec 1. doi: 10.1001/jama.2016.18979.
    PubMed     Text format    


  11. RUGO HS, Barve A, Waller CF, Hernandez-Bronchud M, et al
    Effect of a Proposed Trastuzumab Biosimilar Compared With Trastuzumab on Overall Response Rate in Patients With ERBB2 (HER2)-Positive Metastatic Breast Cancer: A Randomized Clinical Trial.
    JAMA. 2016 Dec 1. doi: 10.1001/jama.2016.18305.
    PubMed     Text format     Abstract available


    November 2016
  12. ABBASI J
    The Nurses' Health Study Takes Fresh Aim at Breast Cancer as It Heads Into Decade Five.
    JAMA. 2016 Nov 23. doi: 10.1001/jama.2016.15976.
    PubMed     Text format    


  13. FOUKAKIS T, von Minckwitz G, Bengtsson NO, Brandberg Y, et al
    Effect of Tailored Dose-Dense Chemotherapy vs Standard 3-Weekly Adjuvant Chemotherapy on Recurrence-Free Survival Among Women With High-Risk Early Breast Cancer: A Randomized Clinical Trial.
    JAMA. 2016;316:1888-1896.
    PubMed     Text format     Abstract available


    October 2016
  14. SLOMSKI A
    Tumor Gene Testing May Help Guide Breast Cancer Treatment Decisions.
    JAMA. 2016;316:1637.
    PubMed     Text format    


  15. VAN DEN BELT-DUSEBOUT AW, van Leeuwen FE, Burger CW
    Breast Cancer Risk After Ovarian Stimulation for In Vitro Fertilization-Reply.
    JAMA. 2016;316:1713-1714.
    PubMed     Text format    


  16. TOMAO F, Papa A, Tomao S
    Breast Cancer Risk After Ovarian Stimulation for In Vitro Fertilization.
    JAMA. 2016;316:1713.
    PubMed     Text format    


    July 2016
  17. VAN DEN BELT-DUSEBOUT AW, Spaan M, Lambalk CB, Kortman M, et al
    Ovarian Stimulation for In Vitro Fertilization and Long-term Risk of Breast Cancer.
    JAMA. 2016;316:300-12.
    PubMed     Text format     Abstract available


    May 2016
  18. CORLEY DA, Haas JS, Kobrin S
    Reducing Variation in the "Standard of Care" for Cancer Screening: Recommendations From the PROSPR Consortium.
    JAMA. 2016;315:2067-8.
    PubMed     Text format    


  19. TAYLOR-PHILLIPS S, Wallis MG, Jenkinson D, Adekanmbi V, et al
    Effect of Using the Same vs Different Order for Second Readings of Screening Mammograms on Rates of Breast Cancer Detection: A Randomized Clinical Trial.
    JAMA. 2016;315:1956-65.
    PubMed     Text format     Abstract available


  20. BURNSIDE ES, Sickles EA, Duffy SW
    A Pragmatic Approach to Determine Components of Optimal Screening Mammography Practice.
    JAMA. 2016;315:1951-3.
    PubMed     Text format    


  21. JACOB JA
    More Women With Breast Cancer Opt for Bilateral Mastectomy Despite Lack of Survival Benefit.
    JAMA. 2016 May 4. doi: 10.1001/jama.2016.3584.
    PubMed     Text format    


    April 2016
  22. RAFFERTY EA, Durand MA, Conant EF, Copit DS, et al
    Breast Cancer Screening Using Tomosynthesis and Digital Mammography in Dense and Nondense Breasts.
    JAMA. 2016;315:1784-6.
    PubMed     Text format    


  23. KRESSIN NR, Gunn CM, Battaglia TA
    Content, Readability, and Understandability of Dense Breast Notifications by State.
    JAMA. 2016;315:1786-8.
    PubMed     Text format    


  24. OEFFINGER KC, Fontham ET, Wender RC
    Clinical Breast Examination and Breast Cancer Screening Guideline--Reply.
    JAMA. 2016;315:1404.
    PubMed     Text format    


  25. ANDERSON BO, Bevers TB, Carlson RW
    Clinical Breast Examination and Breast Cancer Screening Guideline.
    JAMA. 2016;315:1403-4.
    PubMed     Text format    


  26. MYERS ER, Moorman P, Sanders GD
    Breast Cancer Screening: Benefit or Harm?--Reply.
    JAMA. 2016;315:1402-3.
    PubMed     Text format    


  27. JORGENSEN KJ, Gotzsche PC
    Breast Cancer Screening: Benefit or Harm?
    JAMA. 2016;315:1402.
    PubMed     Text format    


  28. KEATING NL, Pace LE
    Screening Mammography and Age Recommendations--Reply.
    JAMA. 2016;315:1405.
    PubMed     Text format    


  29. MOY L
    Screening Mammography and Age Recommendations.
    JAMA. 2016;315:1404-5.
    PubMed     Text format    


    March 2016
  30. HILAL T, Romond EH
    ERBB2 (HER2) Testing in Breast Cancer.
    JAMA. 2016;315:1280-1.
    PubMed     Text format    


  31. HORWITZ RI
    Equity in Cancer Care and Outcomes of Treatment: A Different Type of Cancer Moonshot.
    JAMA. 2016;315:1231-2.
    PubMed     Text format    


  32. JACOB JA
    Protease-Activated Fluorescent Probe Shows Promise as a Cancer Imaging Device.
    JAMA. 2016;315:1217-8.
    PubMed     Text format    


  33. LIN KW, Gostin LO
    A Public Health Framework for Screening Mammography: Evidence-Based vs Politically Mandated Care.
    JAMA. 2016;315:977-8.
    PubMed     Text format    


    February 2016
  34. BLOODGOOD JC
    Cancer of the Breast: Figures Which Show That Education Can Increase the Number of Cures.
    JAMA. 2016;315:709.
    PubMed     Text format    


    January 2016
  35. SHALEV D
    A PIECE OF MY MIND. A Final Course.
    JAMA. 2016;315:263-4.
    PubMed     Text format    


    December 2015
  36. LAMBERTINI M, Boni L, Michelotti A, Gamucci T, et al
    Ovarian Suppression With Triptorelin During Adjuvant Breast Cancer Chemotherapy and Long-term Ovarian Function, Pregnancies, and Disease-Free Survival: A Randomized Clinical Trial.
    JAMA. 2015;314:2632-2640.
    PubMed     Text format     Abstract available


  37. PARTRIDGE AH
    Prevention of Premature Menopause and Preservation of Fertility in Young Cancer Survivors: Hopeful Though Modest Long-term Results.
    JAMA. 2015;314:2625-2627.
    PubMed     Text format    


    November 2015
  38. CHIU HY, Huang HN
    Red-Brown Plaques and Papules in a Patient With Breast Cancer.
    JAMA. 2015;314:2182-3.
    PubMed     Text format    


  39. SLOMSKI A
    Mediterranean Diet With Olive Oil May Reduce Breast Cancer Risk.
    JAMA. 2015;314:2122.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Breast Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: